Tamingthesru

Grand Rounds Recap 9.19.18
Grand Rounds Guest User Grand Rounds Guest User

Grand Rounds Recap 9.19.18

This weeks grand rounds started off with our combined Emergency Medicine and Neurology conference where Dr. Walsh provided us a summary of the current evidence surrounding ICH expansion and reversal of Warfarin and DOACs. This was followed by Dr. Summers who provided suggestions on how we can be more efficient providers in the ED. Dr. Irankunda then presented on the often missed diagnosis of abdominal compartment syndrome. Next up was Dr. Lang who summarized the current evidence for the various available modalities commonly used in treating back pain. Dr. Golden then finished the day with a couple of cases highlighting the challenges in managing the critically ill patient who presents with penetrating neck injuries.

Read More
Grand Rounds Recap 9.12.18
Grand Rounds Guest User Grand Rounds Guest User

Grand Rounds Recap 9.12.18

This week of grand rounds began with an evidence based algorithm for COPD management in the ED with Drs. Lane and Hall. Dr. Faryar then led us through a discussion on various common hand injuries. Dr. Fermann guided us through the management of a feared patient presentation: patients with atrial fibrillation and heart failure. The day continued with Dr. Banning’s Taming the SRU lecture about a case she had of a seizing pregnant patient. Dr. Frederick then gave us an overview of toxic alcohols. The day ended with a pediatric trauma simulation and several pediatric oral boards cases.

Read More
Bug Juice Potpourri
Journal Club, Grand Rounds Jeffery Hill, MD M.Ed Journal Club, Grand Rounds Jeffery Hill, MD M.Ed

Bug Juice Potpourri

In this month's Journal Club, we covered several articles that looked at the use of antibiotics in the Emergency Department.  Does adding Trimethoprim-Sulfamethoxazole to Cephalexin increase the rates of clinical cure in uncomplicated cellulitis? For patients receiving Vancomycin in the ED, how many are appropriately dosed and how many receive a sufficient number of doses to hopefully limit the emergence of resistant bacteria?  Are patients receiving Vancomycin and Piperacillin-Tazobactam really at increased risk of acute kidney injury?

Read More